Have a question? Book your consultation on WhatsApp — we reply in minutes.
Book on WhatsApp
Wegovy (Semaglutide) in Thailand — Physician-Led GLP-1 Program
Healthi Life · Ekkamai 10, Bangkok
Semaglutide is a GLP-1 receptor agonist approved for chronic weight management. At Healthi Life in Thailand, Wegovy is delivered as a physician-supervised, biomarker-monitored program with contraindication review at every step. Prescription medicine.
Indicative — confirmed at physician consultation
您将获得
How Semaglutide Works
GLP-1 Receptor Agonist
Semaglutide activates the GLP-1 receptor to support satiety, glycemic control and appetite regulation.
Physician-Supervised
Initiated and titrated by a licensed physician at Healthi Life Ekkamai.
Biomarker-Monitored
Baseline and follow-up labs (HbA1c, lipids, hepatic, renal) frame every dose adjustment.
Contraindication Review
Personal and family history screening before initiation, including MTC and MEN-2 exclusion.
Subcutaneous Injection
Weekly subcutaneous administration with in-clinic injection training and adherence support.
Longevity Integration
Coordinated with metabolic, hormone and biomarker programs for long-term outcomes.
这适合您吗？
适合人群
- Adults with BMI ≥ 30, or ≥ 27 with a weight-related comorbidity
- Guests who have not reached goals with diet and lifestyle alone
- Candidates committed to monthly follow-up and biomarker review
不建议人群
- Pregnant, planning pregnancy, or breastfeeding women
- Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
- History of pancreatitis or severe gastrointestinal disease
Our 4-Step Wegovy Program
Medical Intake
Full history, medication review, and contraindication screening with the physician.
Baseline Biomarkers
HbA1c, lipid panel, hepatic and renal function established before the first dose.
Titration
Progressive dose escalation 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg based on tolerability.
Monthly Follow-Up
Clinical review, side-effect assessment and dose adjustment every four weeks.
为什么信赖 Healthi Life
医生主导的方案、国际认证以及对曼谷客人安全的承诺。
Regulatory status
Semaglutide is a prescription-only medicine. Under the Thai Drug Act (พ.ร.บ.ยา) a prescription medicine may not be advertised to the general public, and it may only be dispensed and administered after a physician has assessed the individual — it cannot be bought over the counter, online, or through a non-medical seller. Registration status of a medicinal product in Thailand can be checked with the Thai Food and Drug Administration (อย.). It is not appropriate during pregnancy, when planning pregnancy or breastfeeding, with a personal or family history of medullary thyroid carcinoma or MEN-2, or with a history of pancreatitis. This page describes a supervised medical protocol; it is information, not an offer of treatment, and every decision is made with a physician.
选择您的方案
Wegovy 0.25 mg
On request
- Starter / titration dose
- Physician consultation
- Injection training & biomarker review
Wegovy 0.5 mg
On request
- Early titration dose
- Physician consultation
- Injection training & biomarker review
Wegovy 1.0 mg
On request
- Maintenance entry dose
- Physician consultation
- Injection training & biomarker review
Wegovy 2.4 mg
On request
- Full maintenance dose
- Physician consultation
- Injection training & biomarker review
常见问题解答
本页仅供一般信息参考，不构成医疗建议、诊断或治疗。个体结果存在差异。 Wegovy — semaglutide为处方药，须经执业医师评估后方可开具与使用。本页面提供医学信息，并非广告或诊疗要约。 请务必就您的健康状况咨询合格医生。请参阅我们的 完整医疗免责声明.
Book a Wegovy Consultation
Speak with a physician at Healthi Life Ekkamai for eligibility review, baseline biomarkers and a personalized titration plan.
位置
94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110
5 min by taxi from BTS Ekkamai
营业时间
Mon-Sat: 11:00 AM – 7:00 PM
响应时间：2小时内
相关服务
了解其他可与您的健康计划相配合的疗程
Medical Weight Loss Hub
Compare Mounjaro · Wegovy · Retatrutide
了解更多Recovery & Performance
All recovery & performance treatments
了解更多Mounjaro Bangkok
Tirzepatide dual GIP/GLP-1 program
了解更多Ozempic Bangkok
Semaglutide (Ozempic) GLP-1 care
了解更多Retatrutide Bangkok
Investigational triple agonist
了解更多Peptide Therapy
Physician-led peptide programs
了解更多